-
Florida Voters Give Split Decision on GM Mosquitoes [Updated]
Voters in the Florida Keys yesterday returned a split decision on non-binding ballot questions about testing genetically modified mosquitoes to stop the Zika virus.
-
Phone-Based Microscope Developed for Water Testing
An engineering lab at University of Houston in Texas designed an inexpensive lens that when placed over a smartphone’s camera, turns the phone into a microscope.
-
RNA Drug Delivery Technique Shown Safe in Monkeys
A biotechnology company reports a drug delivery method combining nanoscale lipid particles and biocompatible polymers enables the safe production of synthetic RNA-based proteins in monkeys.
-
Zika Vaccine Clinical Trial Underway
The first of a series of clinical trials testing inactivated Zika particles as a vaccine to protect against the live Zika virus is recruiting participants.
-
Patent Awarded for Cancer-Fighting Antibody
A synthetic engineered antibody developed by MabVax Therapeutics that binds to solid tumor cells for cancer diagnostics and treatment received a U.S. patent.
-
Crowdfunded Digital Health Investment Fund Launches
An investment fund raising its capital through crowdfunding began operations this week to back start-up enterprises developing digital health technologies.
-
Lilly, Institute Partner on Tuberculosis Drug Discovery
Drug maker Eli Lilly and Company is continuing its collaboration with Infectious Disease Research Institute to discovery new drugs that treat tuberculosis.
-
Health Insurance Group Forms Academic Research Network
The national organization of Blue Cross-Blue Shield health insurance providers is linking up with academic researchers to study outcomes of health care practices, including opioid abuse and cancer screenings.
-
Safety, Effects Shown in Drug Clearing Alzheimer’s Peptides
An experimental drug that clears peptides associated with Alzheimer’s disease from the central nervous system was also shown to be safe for patients in an early clinical trial.
-
Synthetic Virus Created to Treat Cancer in Dogs
Two companies partnering with Auburn University developed a synthetic virus to find and destroy tumor cells in a type of bone cancer in dogs.